Guru Fundamental Report for PFE

Validea's analysis indicates Pfizer (PFE), a large-cap growth stock in the Biotechnology & Drugs sector, achieved an 85% rating using Meb Faber's Shareholder Yield Investor model. This score signifies 'some interest' from the strategy, which prioritizes companies returning cash to shareholders via dividends, buybacks, and debt paydown, based on PFE's strong underlying fundamentals and valuation alignment with the model's criteria.

Analysis

Pfizer Inc. (PFE) scored 85% on Validea's quantitative model based on Meb Faber's Shareholder Yield strategy, a rating that signifies 'some interest' and indicates a favorable alignment with the model's criteria. The strategy prioritizes companies returning cash to shareholders via dividends, buybacks, and debt reduction. PFE's high score is supported by its passing grades on key tests including Net Payout Yield, Quality and Debt, Valuation, and Relative Strength, pointing to solid underlying fundamentals and an attractive valuation from this specific model's perspective. However, a notable discrepancy exists within the evaluation: despite the strategy's name and PFE passing the 'Net Payout Yield' test, it explicitly failed the 'Shareholder Yield' criterion. This specific failure suggests a nuance or weakness in Pfizer's capital return program that does not meet a particular requirement of the model, introducing a point of ambiguity to the otherwise positive screening.

Key Decisions for Investors

• Investors employing quantitative, yield-focused strategies should view the 85% score and passing marks on valuation and quality as a positive screen, warranting further due diligence on Pfizer.
• It is critical to investigate the specific composition of Pfizer's capital return program to understand why it failed the 'Shareholder Yield' test, as this metric is central to the investment model's thesis.
• Considering PFE is a large-cap growth stock, investors should weigh this specific factor-based analysis against their broader thesis, which may be more dependent on pipeline developments and long-term growth than on immediate shareholder yield metrics.